MILLENNIUM MANAGEMENT LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,361,074
-42.0%
3,112,106
-30.8%
0.00%
-33.3%
Q2 2023$5,799,527
+83793.1%
4,495,757
-14.2%
0.00%
-25.0%
Q1 2023$6,913
+44.6%
5,237,117
+64.3%
0.00%
+33.3%
Q4 2022$4,782
-99.9%
3,188,278
-55.7%
0.00%
-40.0%
Q3 2022$8,499,000
+1100.4%
7,202,938
+1049.5%
0.01%
Q2 2022$708,000
-90.5%
626,642
-74.9%
0.00%
-100.0%
Q1 2022$7,473,000
-38.0%
2,499,480
-45.0%
0.00%
-33.3%
Q4 2021$12,049,000
-18.0%
4,546,869
+12.3%
0.01%
-33.3%
Q3 2021$14,701,000
-26.8%
4,049,924
-12.5%
0.01%
-25.0%
Q2 2021$20,092,000
+59.7%
4,629,583
+25.8%
0.01%
+33.3%
Q1 2021$12,581,000
+249.5%
3,678,755
+257.7%
0.01%
+200.0%
Q4 2020$3,600,000
+136.7%
1,028,480
+62.3%
0.00%
+50.0%
Q3 2020$1,521,000
+47.2%
633,842
+12.3%
0.00%
+100.0%
Q2 2020$1,033,000
-91.9%
564,289
-93.1%
0.00%
-96.6%
Q1 2020$12,736,000
-30.2%
8,163,989
-4.2%
0.03%
+26.1%
Q4 2019$18,244,000
+27.6%
8,525,418
+11.5%
0.02%0.0%
Q3 2019$14,301,000
-18.9%
7,648,121
+13.3%
0.02%
-11.5%
Q2 2019$17,624,000
-1.8%
6,752,437
-3.3%
0.03%
-3.7%
Q1 2019$17,952,000
+13.5%
6,985,308
+1.6%
0.03%
+8.0%
Q4 2018$15,814,000
-35.4%
6,875,804
-9.9%
0.02%
-16.7%
Q3 2018$24,498,000
+162.3%
7,631,800
+131.3%
0.03%
+150.0%
Q2 2018$9,339,000
-47.3%
3,300,077
-34.1%
0.01%
-50.0%
Q1 2018$17,731,000
-18.0%
5,008,672
-10.1%
0.02%
-20.0%
Q4 2017$21,628,000
+213.0%
5,574,333
+104.9%
0.03%
+172.7%
Q3 2017$6,909,000
-48.6%
2,719,919
-44.7%
0.01%
-54.2%
Q2 2017$13,432,000
+33.5%
4,920,182
+61.9%
0.02%
+33.3%
Q1 2017$10,058,000
+170.5%
3,038,693
+94.5%
0.02%
+125.0%
Q4 2016$3,718,000
-55.0%
1,562,075
-30.7%
0.01%
-42.9%
Q3 2016$8,268,000
+56.8%
2,252,688
-4.7%
0.01%
+16.7%
Q2 2016$5,272,000
+8.1%
2,364,117
+0.8%
0.01%0.0%
Q1 2016$4,879,000
-21.3%
2,345,756
+14.7%
0.01%
-7.7%
Q4 2015$6,198,000
+49.6%
2,045,596
+21.9%
0.01%
+62.5%
Q3 2015$4,143,000
-26.5%
1,677,440
-4.5%
0.01%
-27.3%
Q2 2015$5,639,000
-13.2%
1,756,645
-3.4%
0.01%
-8.3%
Q1 2015$6,493,000
+45.2%
1,818,792
-7.7%
0.01%
+33.3%
Q4 2014$4,471,000
-24.6%
1,969,559
-35.6%
0.01%
-40.0%
Q3 2014$5,930,000
-8.3%
3,056,497
+71.6%
0.02%
-16.7%
Q2 2014$6,465,000
-26.4%
1,780,917
-21.4%
0.02%
-28.0%
Q1 2014$8,789,000
-6.1%
2,265,276
-31.0%
0.02%
-16.7%
Q4 2013$9,358,000
-9.6%
3,283,551
+13.6%
0.03%
-9.1%
Q3 2013$10,349,000
+71.8%
2,890,716
+60.3%
0.03%
+83.3%
Q2 2013$6,024,0001,803,5670.02%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders